AstraZeneca, China
AstraZeneca chief says group takes China probe ‘very seriously’
AstraZeneca chief executive Pascal Soriot said the company took the detention of its China president “very seriously”, as the drugmaker raised its guidance for a second straight quarter on the back of strong sales of cancer medicines.
Astra Invests $3.5 Billion in US
AstraZeneca PLC (NASDAQ:AZN) Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good morning to those joining ...
Shares of AstraZeneca PLC AZN rallied 1.54% to £101.44 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.06% to 8,030 ...
Full Year Guidance Upgrade (2024): Total revenue and core EPS expected to grow by high 10s percentage. AstraZeneca PLC ...
U.S. investment of $3.5 billion announced to bolster research and manufacturing. AstraZeneca Plc AZN reported third-quarter ...
Begin your TipRanks Premium journey today. AstraZeneca (AZN) Company Description: Founded in 1992, UK-based AstraZeneca Plc is a leading global pharmaceutical company, which is engaged in ...
CAMBRIDGE, Britain — CAMBRIDGE, Britain — Astrazeneca PLC (AZN) on Tuesday reported third-quarter earnings of $1.43 billion. On a per-share basis, the Cambridge, Britain-based company said it had ...
AstraZeneca is set to report its third-quarter 2024 earnings Tuesday morning. The company's Q2 performance suggests strong ...
The AstraZeneca PLC ADR AZN inched 0.47% higher to $64.79 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.06% ...
AstraZeneca Plc (NASDAQ: AZN) Q3 2024 Earnings Call Nov 12, 2024, 9:00 a.m. ET ...
British drug maker AstraZeneca Plc (AZN.L, AZN) announced Tuesday positive data from global KOMET Phase III trial, in which Koselugo ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback